Abstract
Review of the yeast Saccharomyces boulardii as a treatment option for the inflammatory bowel diseases (IBD) ulcerative colitis and Crohn's disease. IBD is caused by an inappropriate immune response to gut microbiota. Treatment options could therefore be prebiotics, probiotics, antibiotics and/or fecal transplant. In this review, we have looked at the evidence for the yeast S. boulardii as a treatment option. Searches in PubMed and the Cochrane Library with the MeSH words 'Saccharomyces boulardii AND IBD', 'Saccharomyces boulardii AND Inflammatory Bowel Disease', 'Saccharomyces boulardii AND ulcerative colitis' and 'Saccharomyces boulardii AND Crohn's disease' gave total a total of 80 articles. After exclusions because of irrelevance, articles in other languages and some articles that were not available, 16 articles were included in this review. Three of the clinical trials showed a positive effect of S. boulardii in IBD patients (two Crohn's disease, one ulcerative colitis), while there was one trial that didn't prove any effect (Crohn's disease). Included Animal trials and cell assays describes different anti-inflammatory mechanisms of S. boulardii supporting a possible effect when treating IBD patients. The number of studies ...Continue Reading
References
Jul 4, 2003·European Journal of Gastroenterology & Hepatology·Mario GuslandiPier Alberto Testoni
Nov 8, 2006·Gastroenterology·Guillaume DalmassoValerie Brun
Apr 28, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·John H ChidlowChristopher G Kevil
Sep 5, 2007·Alimentary Pharmacology & Therapeutics·D CzeruckaP Rampal
May 27, 2008·Nature Reviews. Immunology·Judy H Cho
Jun 28, 2008·Scandinavian Journal of Gastroenterology·Eduardo Garcia VilelaAloísio Sales Da Cunha
Aug 27, 2009·Alimentary Pharmacology & Therapeutics·C Pothoulakis
Apr 13, 2011·PloS One·Alexandra CanoniciFrédéric André
Jun 4, 2011·Gut Microbes·Ian RowlandRémy Meier
Sep 10, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Saskia ThomasDaniel C Baumgart
Apr 25, 2012·PloS One·Marina L Ritchie, Tamara N Romanuk
Oct 3, 2012·PloS One·Alexandra CanoniciFrédéric André
Jan 5, 2013·Current Opinion in Gastroenterology·Kevin Whelan, Eamonn M M Quigley
Mar 8, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Arnaud BourreilleUNKNOWN FLORABEST Study Group
May 16, 2013·PloS One·Xinhua ChenCiaran P Kelly
Sep 11, 2014·World Journal of Gastroenterology : WJG·Rok Orel, Tina Kamhi Trop
Apr 29, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·José Garrido-MesaJulio Galvez
May 20, 2015·Gastroenterology·Colleen R KellyGary Wu
Jul 5, 2015·Applied Microbiology and Biotechnology·Mariana L PalmaBruno Douradinha
Jul 29, 2015·The ISME Journal·Thomas W HoffmannHarry Sokol
Mar 16, 2017·Journal of Cellular Physiology·Mahboube Ganji-Arjenaki, Mahmoud Rafieian-Kopaei
Mar 24, 2017·Journal of Crohn's & Colitis·Chloé TercioloFrédéric André
Sep 15, 2017·Inflammatory Bowel Diseases·Neeraj NarulaPaul Moayyedi
Citations
Jun 13, 2020·Expert Opinion on Therapeutic Patents·Farzin RoohvandNiloufar Kossari
Apr 27, 2019·Frontiers in Immunology·Renata CurciarelloCecilia Isabel Muglia
Dec 9, 2020·Journal of Applied Microbiology·Mayana Rodrigues S RibeiroMaria Aparecida Gomes
Apr 4, 2021·Nutrients·Marjo J E Campmans-Kuijpers, Gerard Dijkstra
Jul 3, 2021·Nutrients·Leontien Depoorter, Yvan Vandenplas
Nov 28, 2021·International Journal of Molecular Sciences·Adi Eindor-AbarbanelKevan Jacobson
Dec 9, 2021·Food & Function·Bei LiZhi Liu